Maurizio Nicolelli
Known title: Executive Vice President & CFOCIK: 0001472650
Maurizio Nicolelli's purchase track record
Maurizio Nicolelli has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/17/2023 | EXLS | $114K | -0.3% | -4.3% | +13.6% |
| 3/14/2022 | EXLS | $149K | +10.4% | +42.2% | -1.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| EXLS | ▲ Buy | Grant | 606 | $14K | 6/30/2026 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 5,587 | $0 | 2/27/2026 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 2,199 | $68K | 2/27/2026 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,215 | $0 | 2/20/2026 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,659 | $50K | 2/20/2026 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,855 | $0 | 2/17/2026 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,911 | $57K | 2/17/2026 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,110 | $0 | 2/17/2026 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,618 | $49K | 2/17/2026 | View on chart |
| EXLS | ▲ Buy | Grant | 11,458 | $0 | 1/26/2026 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 4,509 | $192K | 1/26/2026 | View on chart |
| EXLS | ▲ Buy | Grant | 21,774 | $0 | 1/26/2026 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 8,569 | $365K | 1/26/2026 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 5,315 | $221K | 1/21/2026 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 13,925 | $595K | 12/31/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 5,480 | $234K | 12/31/2025 | View on chart |
| EXLS | ▲ Buy | Grant | 565 | $22K | 6/30/2025 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 5,587 | $0 | 2/27/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 2,199 | $107K | 2/27/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,618 | $82K | 2/18/2025 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 8,650 | $0 | 2/18/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 3,404 | $173K | 2/18/2025 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,855 | $0 | 2/18/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,911 | $97K | 2/18/2025 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,110 | $0 | 2/18/2025 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 23,310 | $0 | 1/27/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 6,282 | $309K | 1/27/2025 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 34,950 | $0 | 1/27/2025 | View on chart |
| EXLS | ▼ Sell | Open Market | 13,753 | $676K | 1/27/2025 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 10,655 | $389K | 9/3/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 27,075 | — | 9/1/2024 | View on chart |
| EXLS | ▲ Buy | Grant | 810 | $22K | 7/1/2024 | View on chart |
| EXLS | ▼ Sell | Open Market | 12,000 | $368K | 5/8/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 5,460 | $0 | 2/19/2024 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 2,149 | $66K | 2/19/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 8,650 | $0 | 2/17/2024 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 3,404 | $104K | 2/17/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,855 | $0 | 2/16/2024 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,911 | $59K | 2/16/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 4,110 | $0 | 2/15/2024 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,618 | $49K | 2/15/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 7,375 | $0 | 2/5/2024 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 2,903 | $89K | 2/5/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 69,200 | $0 | 1/29/2024 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 27,515 | $888K | 1/29/2024 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 13,530 | $0 | 9/1/2023 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 5,325 | $156K | 9/1/2023 | View on chart |
| EXLS | ▲ Buy | Grant | 144 | $20K | 6/30/2023 | View on chart |
| EXLS | ▲ Buy | Open Market | 750 | $114K | 3/17/2023 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 1,091 | $0 | 2/19/2023 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 430 | $73K | 2/19/2023 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 1,730 | $0 | 2/17/2023 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 681 | $116K | 2/17/2023 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 971 | $0 | 2/16/2023 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 383 | $66K | 2/16/2023 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 1,474 | $0 | 2/3/2023 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 581 | $101K | 2/3/2023 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 6,547 | $0 | 1/30/2023 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 1,738 | $295K | 1/30/2023 | View on chart |
| EXLS | ▲ Buy | Grant | 105 | $14K | 12/30/2022 | View on chart |
| EXLS | ▲ Buy | Open Market | 1,200 | $149K | 3/14/2022 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 1,091 | $0 | 2/19/2022 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 266 | $30K | 2/19/2022 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 1,730 | $0 | 2/17/2022 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 422 | $51K | 2/17/2022 | View on chart |
| EXLS | ▲ Buy | Option Exercise | 1,475 | $0 | 2/3/2022 | View on chart |
| EXLS | ▼ Sell | Tax Withholding | 491 | $60K | 2/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
EXL adds agentic AI to insurance and healthcare solutions
EXL announced that it is embedding agentic AI into its core insurance and healthcare offerings to streamline client workflows. The company also set the date for its third‑quarter 2026 financial results conference call. The AI rollout could affect future service capabilities, while the upcoming call will give investors more insight into recent performance.
EXL adds agentic AI to insurance and healthcare solutions. EXL announced that it is embedding agentic AI into its core insurance and healthcare offerings to streamline client workflows. The company also set the date for its third‑quarter 2026 financial results conference call. The AI rollout could affect future service capabilities, while the upcoming call will give investors more insight into recent performance.